companydata.dkcompanydata.dk

Valeos Pharma A/S: Financial statements 2024

CVR: 39696614

Source: annual report 2024, Danish Business Authority

01/01/2024 – 31/12/2024

Valeos Pharma A/S (CVR 39696614) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK -3,846,790 and a net result of DKK -16,944,710 compared with DKK -16,533,984 the year before. Equity in the 2024 report amounted to DKK 6,800,195. The solvency ratio was 11.7%. The company had 19 employees in the financial year.

Gross Profit
DKK -3,846,790
Profit/Loss
DKK -16,944,710
Equity
DKK 6,800,195
Total Assets
DKK 58,143,640
Employees
19

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2024--3.8M-16.9M6.8M19
2023--5.8M-16.5M-8.4M18
2022--6.5M-11.4M5.1M10
2021--3.4M-6.4M16.5M7
2020--1.3M-1.7M-1.4M2

Official annual report

View the official annual report directly on the page with a Pro subscription.

Screen every Danish company

Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.

Try company screening

Events in 2024

A. Rosen Holding ApS registered as owner of Valeos Pharma A/SNov 7, 2024

As of November 7, 2024, A. Rosen Holding ApS is registered as an owner of Valeos Pharma A/S with an ownership share of 15%.

MSG Capital APS registered as owner of Valeos Pharma A/SNov 7, 2024

As of November 7, 2024, MSG Capital APS is registered as an owner of Valeos Pharma A/S with an ownership share of 50%.

Kleingut ApS registered as owner of Valeos Pharma A/SNov 7, 2024

As of November 7, 2024, Kleingut ApS is registered as an owner of Valeos Pharma A/S with an ownership share of 10%.

Valeos Pharma A/S: The 2023 annual report is outJul 3, 2024

Valeos Pharma A/S has published its annual report for 2023. Gross profit came to DKK -5,838,506, and the net result was DKK -16,533,984.

Morten Larsen Snede joins Valeos Pharma A/S as adm. dir.Feb 12, 2024

As of February 12, 2024, Morten Larsen Snede is registered as adm. dir. of Valeos Pharma A/S.

Peter Frederik Andreasen steps down as adm. dir. of Valeos Pharma A/SFeb 12, 2024

As of February 12, 2024, Peter Frederik Andreasen has stepped down as adm. dir. of Valeos Pharma A/S.

About Valeos Pharma A/S

Valeos Pharma A/S is a Danish company of the type Aktieselskab based in Holeby, founded in 2018. The company is registered under the industry Fremstilling af farmaceutiske præparater. The company was previously named Valeos A/S and Valeos ApS. The management consists of Peter Frederik Andreasen. The board consists of Glenn Steven Nielsen (chair), Kristian Schrøder Hart-Hansen, Michael Halborg-Bendtsen and Peter Frederik Andreasen. The company is owned by A. Rosen Holding ApS, MSG Capital APS and Kleingut ApS. The company has 21 employees (2026). In 2025, the company reported a gross profit of DKK 975,949 and a net result of DKK -13,487,363 compared with DKK -16,944,710 the year before. Equity in the 2025 report amounted to DKK -6,687,169.

Source: annual report 2025, Danish Business Authority

Other financial years